| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.21 | 0.06 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |